LPCN vs TFC · rev $309.5K vs rev $11.82B
Lipocine Inc (LPCN) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
TFC (TFC) common stock.
Latest reported LPCN revenue for 2026-06-30 was $309.5K. Net income was -$6.3M. LPCN currently screens at market cap $19.3M.
Latest reported TFC revenue for 2026-06-30 was $11.82B. Net income was $3.03B. TFC currently screens at market cap $0.
LPCN currently screens at market cap $19.3M. TFC currently screens at market cap $0.
Not investment advice. Open the LPCN and TFC stock pages for the full models.
Not investment advice.